Executive functions in premanifest Huntington's disease

Movement Disorders

Volumn 29, Issue 3, 2014, Pages 405-409

  You, S Christine ^a   Geschwind, Michael D ^a   Sha, Sharon J ^a   Apple, Alexandra ^b   Satris, Gabriella ^a   Wood, Kristie A ^a   Johnson, Erica T ^a   Gooblar, Jonathan ^a   Feuerstein, Jeanne S ^a   Finkbeiner, Steven ^a,c,d   Kang, Gail A ^a   Miller, Bruce L ^a   Hess, Christopher P ^b   Kramer, Joel H ^a   Possin, Katherine L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^d Hellman Family Foundation Program in Alzheimer's Disease Research   (United States)

Author keywords

Disease burden; Executive function; Huntington's disease; Striatal volume; Working memory

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE BURDEN; DISEASE MARKER; EXECUTIVE COMPOSITE SCORE; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVOUS SYSTEM PARAMETERS; NIH EXAMINER; PRIORITY JOURNAL; SCORING SYSTEM; STRIATAL VOLUME; WORKING MEMORY; AGED; COGNITIVE DEFECT; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SHORT TERM MEMORY;

ADULT; AGED; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84896140168     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25762     Document Type: Article

References (38)

1. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2011;8:791-801.
2. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62:1341-1346.
3. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008;79:874-880.
4. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation-a longitudinal follow-up study. J Neurol. 2004;251:935-942.
5. Solomon AC, Stout JC, Johnson SA, et al. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia. 2007;45:1767-1776.
6. Johnson SA, Stout JC, Solomon AC, et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain. 2007;130:1732-1744.
7. Lawrence AD, Hodges JR, Rosser AE, et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain. 1998;121:1329-1341.
8. Papp KV, Snyder PJ, Mills JA, et al. Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease. Arch Clin Neuropsychol. 2013;28:156-168.
9. Snowden JS, Craufurd D, Thompson J, Neary D. Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol. 2002;24:133-145.
10. Beglinger LJ, O'Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS. Earliest functional declines in Huntington disease. Psychiatry Res. 2010;178:414-418.
11. Cahn-Weiner DA, Boyle PA, Malloy, PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol. 2002;9:187-191.
12. Nehl C, Paulsen JS. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity. J Nerv Ment Dis. 2004;192:72-74.
13. Duff K, Paulsen JS, Beglinger LJ, et al. "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci. 2010;22:196-207.
14. Prigatano GP. Anosognosia: clinical and ethical considerations. Curr Opin Neurol. 2009;22:606-611.
15. Hart E, Middelkoop H, Jurgens CK, Witjes-Ané MN, Roos RA. Seven-year clinical follow-up of premanifest carriers of Huntington's disease. PLoS Curr. 2011;3:RRN1288.
16. Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci. 2005;239:11-19.
17. Aylward EH, Liu D, Nopoulos PC, et al. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry. 2012;71: 822-828.
18. Pirogovsky E, Goldstein J, Peavy G, Jacobson MW, Corey-Bloom J, Gilbert PE. Temporal order memory deficits prior to clinical diagnosis in Huntington's disease. J Int Neuropsychol Soc. 2009;15:662-670.
19. Stout JC, Paulsen JS, Queller S, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 2011;25:1-14.
20. Dumas EM, Say MJ, Jones R, et al. Visual working memory impairment in premanifest gene-carriers and early Huntington's disease. J Huntingtons Dis. 2012;1:97-106.
21. Crane PK, Narasimhalu K, Gibbons LE, et al. Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol. 2008;61:1018-1027.e9.
22. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2012;83:612-619.
23. Gibbons LE, Carle AC, Mackin RS, et al. A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 2012;6:517-527.
24. Mungas D, Reed BR, Kramer JH. Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology. 2003;17: 380-392.
25. Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:751-763.
26. Kramer JH, Mungas D, Possin KL, et al. NIH EXAMINER: Conceptualization and Development of an Executive Function Battery. J Int Neuropsychol Soc. 2013 [Epub ahead of print].
27. Cohen J. A power primer. Psychol Bull. 1992;112:155-159.
28. Georgiou-Karistianis N, Stout JC, Domínguez D JF, et al. Functional magnetic resonance imaging of working memory in Huntington's disease: Cross-sectional data from the IMAGE-HD study. Hum Brain Mapp. 2013;34 [Epub ahead of print].
29. Larsson MU, Almkvist O, Luszcz MA, Wahlin TB. Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease. Neuropsychology. 2008;22:596-605.
30. Henry JD, Crawford JR, Phillips LH. A meta-analytic review of verbal fluency deficits in Huntington's disease. Neuropsychology. 2005;19:243-252.
31. Beste C, Saft C, Yordanova J, et al. Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease? Neuropsychologia. 2007;45:2922-2930.
32. Possin KL, Lamarre AK, Wood KA, Mungas DM, Kramer JH. Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score. J Int Neuropsychol Soc. 2013:1-9 [Epub ahead of print].
33. Finkbeiner S. Bridging the Valley of Death of therapeutics for neurodegeneration. Nat Med. 2010;16:1227-1232.
34. Haik KL, Shear DA, Schroeder U, Sabel BA, Dunbar GL. Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease. Exp Neurol. 2000;163:430-439.
35. Kolata W, Kolata S. A model of working memory capacity in the radial-arm maze task. J Math Psychol. 2009;53:242-252.
36. Trueman RC, Jones L, Dunnett SB, Brooks SP. Early onset deficits on the delayed alternation task in the Hdh(Q92) knock-in mouse model of Huntington's disease. Brain Res Bull. 2012;88:156-162.
37. Romberg C, Horner, AE, Bussey TJ, Saksida LM. A touchscreen-automated cognitive test battery reveals impaired attention, memory abnormalities and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease. Neurobiol Aging. 2013;34:731-744.
38. Bizon JL, Foster TC, Alexander GE, Glisky EL. Characterizing cognitive aging of working memory and executive function in animal models. Front Aging Neurosci. 2012;4:19.